Literature DB >> 6117563

Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam.

D J Greenblatt, M Divoll, L J Moschitto, R I Shader.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6117563     DOI: 10.1016/s0378-4347(00)80261-3

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  23 in total

1.  The pharmacokinetics and pharmacodynamics of sublingual and oral alprazolam in the post-prandial state.

Authors:  J M Scavone; D J Greenblatt; J E Goddard; H Friedman; J S Harmatz; R I Shader
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Forensic analysis of triazolam in human tissues using capillary gas chromatography.

Authors:  K Kudo; T Nagata; T Imamura; S Kage; Y Hida
Journal:  Int J Legal Med       Date:  1991-03       Impact factor: 2.686

Review 3.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

4.  Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.

Authors:  H R Ochs; D J Greenblatt; M Knüchel
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.

Authors:  E H Ellinwood; D G Heatherly; A M Nikaido; T D Bjornsson; C Kilts
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.

Authors:  P D Kroboth; R B Smith; M R Silver; R Rault; M I Sorkin; J B Puschett; R P Juhl
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

7.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

8.  Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.

Authors:  J M Scavone; G T Blyden; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

Review 9.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

10.  The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.

Authors:  D R Abernethy; D J Greenblatt; M Divoll; R B Smith; R I Shader
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.